Backtracking NOM1::ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AML

This research was partially supported by a donation from the patient’s family and Heroga Fertilizantes. Research in PM’s laboratory is supported by CERCA/Generalitat de Catalunya and Fundació Josep Carreras-Obra Social la Caixa for core support, the European Research Council grants (ERC-PoC-957466, ERC-PoC-101100665), the H2020 EU program (101057250-CANCERNA), the MINECO (PID2022-142966OB-I00/MCIN/AEI/10.13039/501100011033 and Feder Funds), the MINECO/European Union NextGenerationEU (CPP2021-008508, CPP2022-009759); the Deutsche José Carreras Leukämie-Stiftung (DJCLS15R/2021 and DJCLS 02R/2023), the Spanish Association Against Cancer (AECC, PRYGN234975MENE) and the ISCIII-RICORS within the Next Generation EU program (plan de Recuperación, Transformación y Resilencia). Research in XSP’s laboratory is supported by Ministerio de Ciencia e Innovación (PID2020-117185RB-I00); the Spanish Association Against Cancer (AECC); Centro de Investigación Biomédica en Red Cáncer (CIBERONC); “La Caixa” Foundation CLLSYSTEMS (HR22-00172), European Union NextGenerationEU/Mecanismo para la Recuperación y la Resilencia (MRR)/PRTR and the Instituto de Salud Carlos III (ISCIII) (PMP21/00015). OM and TV-H were supported by an investigator award from AECC (INVES211226MOLI and INVES223069VELA, respectively).